Catalyst Science Discovery Centre appoints director

Widnes, Cheshire-based firm welcomes Stephen Youd-Thomas

Catalyst Science Discovery Centre, an interactive science centre and museum devoted to chemistry and how the products of chemistry are used in everyday life based in Widnes, Cheshire, UK, has a new director of catalyst, which encompasses the role of ERDF project director.

Stephen Youd-Thomas runs a successful corporate and social responsibility consultancy and was formerly head of social goals at the Co-operative Group.

‘This is a wonderful opportunity to help develop the work of the UK's only science discovery centre with chemistry as its main theme. Catalyst brings chemistry alive for thousands of young people from across the North West and beyond and hopefully this experience will encourage many of them to consider a career in science in the future,’ he said.

Catalyst is an independent charitable trust operated by Catalyst Science Discovery Centre and Museum Trust.

You may also like

Pharmaceutical

AIRPLAN S.A. showcases its dual strength in engineering and technology at CPHI 2025

AIRPLAN S.A. will once again participate in CPHI 2025, the world’s premier pharmaceutical event, taking place from October 28 to 30 in Frankfurt (Hall 9.0, booth B29)
Manufacturing

Thermo Fisher expands collaboration Multiply Labs for automated cell therapy manufacturing

The strategic collaboration will aim to integrate robot automation with the Gibco CTS DynaCellect Magnetic Separation System for a more efficient manufacturing process
Pharmaceutical

NEXTEN: Tomorrow's Tableting Innovations

A world première of the new IMA Active tablet presses
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Human-machine symbiosis: why Industry 5.0 is the future of pharmaceutical manufacturing

Industry 5.0 is reshaping pharmaceutical manufacturing by fostering human-machine collaboration, addressing workforce shortages and making advanced automation accessible to all through innovative models such as robot rental
Research & Development

Veraxa and Secarna Pharmaceuticals partner to advance AOC therapies for immune diseases

The pair will develop next-generation antibody oligonucleotide conjugates (AOCs) with the aim of unlocking novel targeted therapies for the treatment of autoimmune and chronic immune diseases
Manufacturing

The future of powder dispersion

ystral presented high-shear vacuum expansion technology at POWTECH
Pharmaceutical

Global vaccine patents up 7% in a year despite US government's stance

Vaccine patent applications show sustained momentum after the COVID pandemic, with RNA vaccines now dominating the filings
Subscribe now